Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heron Therapeutics (HRTX) Current Assets (2016 - 2025)

Historic Current Assets for Heron Therapeutics (HRTX) over the last 14 years, with Q3 2025 value amounting to $229.4 million.

  • Heron Therapeutics' Current Assets rose 1752.83% to $229.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $229.4 million, marking a year-over-year increase of 1752.83%. This contributed to the annual value of $209.0 million for FY2024, which is 1072.18% up from last year.
  • According to the latest figures from Q3 2025, Heron Therapeutics' Current Assets is $229.4 million, which was up 1752.83% from $210.9 million recorded in Q2 2025.
  • Heron Therapeutics' Current Assets' 5-year high stood at $366.8 million during Q2 2021, with a 5-year trough of $165.3 million in Q2 2023.
  • Moreover, its 5-year median value for Current Assets was $209.0 million (2024), whereas its average is $221.9 million.
  • As far as peak fluctuations go, Heron Therapeutics' Current Assets crashed by 4705.69% in 2022, and later surged by 1752.83% in 2025.
  • Heron Therapeutics' Current Assets (Quarter) stood at $254.4 million in 2021, then fell by 19.25% to $205.4 million in 2022, then fell by 8.11% to $188.8 million in 2023, then grew by 10.72% to $209.0 million in 2024, then increased by 9.75% to $229.4 million in 2025.
  • Its Current Assets was $229.4 million in Q3 2025, compared to $210.9 million in Q2 2025 and $212.8 million in Q1 2025.